Latest News and Press Releases
Want to stay updated on the latest news?
-
–$995 per carton (two 40 mg/0.8 mL autoinjectors) represents a discount of more than 85% compared to Humira® – – YUSIMRY™ meets high unmet need by providing patients, employers, physicians and...
-
SCOTTSDALE, Ariz., July 03, 2023 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on the selling...
-
Dublin, July 03, 2023 (GLOBE NEWSWIRE) -- The "Livestock Insurance Market Size, Share & Trends Analysis Report By Coverage (Mortality, Revenue), By Animal Type, By Distribution Channel, By...
-
Austin, TX, USA, July 03, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Metal Tank Market Size, Trends and Insights By End Use Industry (Oil and gas,...
-
Acquisition catalyzes disruptive real time B2B credit risk management solutions Enhances Sidetrade’s offer with the most advanced solution and responds to booming B2B e-commerce market Sidetrade...
-
Une avancée majeure dans la gestion temps réel du risque de crédit interentreprises : L’offre de Sidetrade s’enrichit de la solution la plus élaborée et répond à l'essor e-commerce en BtoB ...
-
Hyrimoz® (adalimumab-adaz) high-concentration formulation (HCF) biosimilar offers US patients reduced injection volume in citrate-free formulationAs one of the only adalimumab HCF biosimilars approved...
-
ENENTO GROUP PLC, STOCK EXCHANGE RELEASE 30 JUNE 2023 AT 7.00 P.M. EEST Enento Group completes repurchasing own shares Enento communicated on 24 April 2023, that its Board of Directors...
-
LOS ALTOS, Calif., June 29, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
-
Enento Group Plc Stock Exchange Release 29 June 2023 at 9:40 p.m. EEST Enento Group notes the recent movement in the company’s share price The Board of Directors of Enento Group Plc...